Assignee
NORDIC NANOVECTOR ASA
NO·1 granted patent·5 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
6 records- 0151US10646599B2Method for upregulating antigen expressionNORDIC NANOVECTOR ASA·Filed 2018·Granted May 12, 2020·0 cites·5 claims
- 0249US2022160907A1Treatment of non-hodgkin lymphoma using lilotomab and 177lu-lilotomab satetraxetanNORDIC NANOVECTOR ASA·Filed 2021·Application pending·0 cites
- 0347US2025333531A1Humanized hh1NORDIC NANOVECTOR ASA·Filed 2022·Application pending·0 cites
- 0439US2018194852A1Chimeric therapeutic anti - cd37 antibodie hh1NORDIC NANOVECTOR ASA·Filed 2017·Application pending·0 cites
- 0537US2019192703A1Treatment of non-hodgkin lymphoma using lilotomab and 177lu-lilotomab satetraxetanNORDIC NANOVECTOR ASA·Filed 2017·Application pending·0 cites
- 0624US2021106703A1Radioimmunoconjugates in combination with other drugs as treatment against nhlNORDIC NANOVECTOR ASA·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →